View all sections
Reset
News - Commercial Aviation
Fuji Dream Airlines expands all-Embraer fleet in Japan with additional E175 orders
July 21, 2026
Airline is consistently recognized in Japan for its on-time performance
Delivery begins in 2027
Airline is consistently recognized in Japan for its on-time performance
Delivery begins in 2027
Farnborough Airshow, UK – July 21, 2026 – Embraer (NYSE: ERJ; B3: EMBJ3) announced at the Farnborough Airshow that Fuji Dream Airlines (FDA) has placed a firm order for two E175 aircraft. The order is already reflected in Embraer’s backlog.
FDA's new E175 aircraft will be configured in a single-class 84-seat layout, with deliveries scheduled for 2027 and 2028. The E175's proven performance on high-frequency operations and shorter routes makes it a leading choice for airlines like FDA as they continue to develop their regional networks.
Shunsuke Honda, President of Fuji Dream Airlines, said, "FDA currently operates a fleet of 15 Embraer aircraft, consisting of two E170s and thirteen E175s. The introduction of these new aircraft will enhance our capacity and help further strengthen our network connecting communities across Japan. We are also very pleased that this order represents an opportunity to further develop our long-standing partnership with Embraer.”
Arjan Meijer, President and CEO of Embraer Commercial Aviation, said, "Fuji Dream Airlines’ outstanding operations and its team’s relentless pursuit of excellence have greatly contributed to Japan’s regional aviation sector. It also reflects the E-Jets’ ability to deliver a high standard of reliability, performance, efficiency and passenger comfort. We are honoured to be a partner in FDA’s growth and will continue to deliver exceptional value to the airline."
FDA is a full-service regional airline that has operated E-Jets since commencing operations in 2009. The airline has consistently been recognized for its strong operational and on-time performance in Japan. The fleet’s 12-month average schedule reliability, an indicator of aircraft quality and maintenance standards stand at more than 99.8%.
Images: Embraer DAM
About Fuji Dream Airlines (FDA) and Suzuyo Group
Fuji Dream Airlines (FDA) was established in 2008 as the aviation business of the Suzuyo Group and operates as a regional airline connecting communities across Japan. Today, FDA operates a network of 29 routes serving 17 airports nationwide, with major bases at Shizuoka, Nagoya (Komaki), Matsumoto, and Fukuoka airports.
One of FDA's distinctive features is its "Multi-Color Concept," under which each of its 15 aircraft is painted in a unique livery, creating a colorful and recognizable fleet.
The Suzuyo Group, founded in 1801, is a diversified corporate group with logistics at its core and operations spanning trading, construction, real estate, information services, and other business sectors.
As the Group's airline company, FDA provides community-focused air transportation services that contribute to regional connectivity, interregional exchange, and regional economic development.
About Embraer
A global aerospace company headquartered in Brazil, Embraer has businesses in Commercial and Executive aviation, Defense and Security, and Agricultural Aviation. The company designs, develops, manufactures, and markets aircraft and systems, providing Services and Support to customers after-sales.
Since it was founded in 1969, Embraer has delivered more than 9,000 aircraft. On average, about every 10 seconds an aircraft manufactured by Embraer takes off somewhere in the world, transporting over 145 million passengers a year.
Embraer is the leading manufacturer of commercial jets with up to 150 seats and the main exporter of high- value-added goods in Brazil. The company maintains industrial units, offices, service, and parts distribution centers, among other activities, across the Americas, Africa, Asia, and Europe.
Previous 
CLOSE
